RecruitingNot ApplicableNCT06082531

Effect of Platelet-rich Plasma (PRP) Injection on Knee Osteoarthritis

Therapeutic Effect of Platelet-rich Plasma (PRP) Injection on Knee Osteoarthritis and Periarticular Tissue Injury

Sponsor

Xijing Hospital

Enrollment

300 participants

Start Date

Sep 1, 2023

Study Type

INTERVENTIONAL

Conditions

Meniscus Disorder Osteoarthritis Knees Both Platelets-rich Plasma Cartilage Injury

Summary

To evaluate the safety and effectiveness of PRP injection therapy in the repair of osteoarthritis and periarticular soft tissue injury through a single-center, exploratory clinical study, and to provide a more reliable basis for the treatment of joint injury.

Eligibility

Min Age: 20 YearsMax Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Sodium hyaluronate injection for people with cartilage injury, meniscus disorder, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 20 Years to 60 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.